Yet oncology products have a greater likelihood than other therapy areas to fail at Phase III (see graph) – well after the branding process has already begun and market expectations are somewhat ...

Beacon reported 2023 revenue of $9.3 billion, and its share price is up 14% year-to-date.

Researchers observed improvements in rates of burnout and work-life integration challenges among a cohort of U.S. medical oncology fellows in 2023 vs. 2013, but challenges remain, according to ...

It’s clear the growth rate for oncology products is slowing. Figure 1 Global Oncology Sales and Growth Considering this moderating growth, IMS conducted an Oncology Launch Excellence Study to ...

Oncology is the branch of medicine that deals with the diagnosis and treatment of cancer. It includes medical oncology (the use of chemotherapy, hormone therapy, and other drugs to treat cancer ...

After hours: February 7 at 5:35:45 PM EST Loading Chart for POAI ...

After hours: February 7 at 4:20:00 PM EST Loading Chart for BECN ...

The firm's oncology business had Q4 revenues of $4.06 billion compared to $3.19 billion in Q4 2023, a 27 percent increase. The oncology products gained in the 2023 Seagen acquisition, including Tukysa ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...